CIK 0001314102
- Non-accelerated filer
- Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262774444
- Phone
- +1 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- 4 Exercise or conversion Director acquired 12,666 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Gift Chief Financial Officer gave 5,000 shares (gift)
- 4 Open-market sale Former 10% Owner sold 60,000 shares at $15.70 ($942,240)
- 4 Planned sale Director sold 9,300 shares at $15.11 ($140,477)
- 4 Planned sale Director sold 700 shares at $14.95 ($10,465)
- 4 Planned sale Chief Medical Officer sold 2,722 shares at $11.61 ($31,602)
- 4 Gift Chief Financial Officer gave 20,000 shares (gift)
- 4 Exercise or conversion Director acquired 2,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 11,111 shares (option exercise)
- 4 Shares withheld for taxes President and CEO gave up 7,688 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Other disposition President and CEO disposed of 56,665 shares (other)
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,202 shares (to pay taxes)
- 4 Open-market buy Director bought 10,000 shares at an average $5.90 ($59,000)
- 4 Open-market buy Director bought 10,000 shares at an average $5.45 ($54,450)
Page 2 of 23 · 459 filings